Safety and Effectiveness of EN3835 in the Treatment of EFP in Women
NCT03329989
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
158
Enrollment
INDUSTRY
Sponsor class
Conditions
Edematous Fibrosclerotic Panniculopathy
Cellulite
Interventions
BIOLOGICAL:
Collagenase Clostridium Histolyticum
Sponsor
Endo Pharmaceuticals